期刊文献+

Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization 被引量:3

Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization
下载PDF
导出
摘要 Most patients with hepatocellular carcinoma (HCC) are not eligible for curative treatment, which is resection or transplantation. Two recent series have emphasized the potential benefits of preoperative arterio-portal embolization prior to surgical resection of such tumours. This preoperative strategy offers a better disease free survival rate and a higher rate of total tumor necrosis. In case of non resectable HCC it is now widely accepted that transarterial chemoembolization (TACE) leads to a better survival when compared to conservative treatment. Thus, the question remains whether combined portal vein embolization (PVE) may enhance the proven efficiency of TACE in patients with unresectable HCC. We herein report the case of a 56-year-old cirrhotic woman with a voluminous HCC unsuitable for surgical resection. Yet, complete turnout necrosis and prolonged survival could be achieved a^er a combined porto-arterial embolization. This case emphasizes the potential synergistic effect of a combined arterio-portal embolization and the hypothetical survival benefit of such a procedure, in selected patients, with HCC not suitable for surgery or local ablative therapy. Most patients with hepatocellular carcinoma (HCC) are not eligible for curative treatment,which is resection or transplantation. Two recent series have emphasized the potential benefits of preoperative arterio-portal embolization prior to surgical resection of such tumours. This preoperative strategy offers a better disease free survival rate and a higher rate of total tumor necrosis. In case of non resectable HCC it is now widely accepted that transarterial chemoembolization (TACE) leads to a better survival when compared to conservative treatment. Thus,the question remains whether combined portal vein embolization (PVE) may enhance the proven efficiency of TACE in patients with unresectable HCC. We herein report the case of a 56-year-old cirrhotic woman with a voluminous HCC unsuitable for surgical resection. Yet,complete tumour necrosis and prolonged survival could be achieved after a combined porto-arterial embolization. This case emphasizes the potential synergistic effect of a combined arterio-portal embolization and the hypothetical survival benefit of such a procedure,in selected patients,with HCC not suitable for surgery or local ablative therapy.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第44期6869-6872,共4页 世界胃肠病学杂志(英文版)
关键词 Hepatocellular carcinoma Sequentialarterio-portal embolization Palliative treatment 肝细胞癌 肝门栓塞 细胞坏死 治疗方法
  • 相关文献

参考文献25

  • 1[1]Bruix J,Llovet JM.Prognostic prediction and treatment strategy in hepatocellular carcinoma.Hepatology 2002; 35:519-524
  • 2[2]Trinchet JC,Beaugrand M.Treatment of hepatocellular carcinoma in patients with cirrhosis.J Hepatol 1997; 27:756-765
  • 3[3]Bruix J,Sherman M,Llovet JM,Beaugrand M,Lencioni R,Burroughs AK,Christensen E,Pagliaro L,Colombo M,Rodes J.Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL conference.European Association for the Study of the Liver.J Hepatol 2001; 35:421-430
  • 4[4]Lai EC,Fan ST,Lo CM,Chu KM,Liu CL,Wong J.Hepatic resection for hepatocellular carcinoma.An audit of 343 patients.Ann Surg 1995; 221:291-298
  • 5[5]Llovet JM,Burroughs A,Bruix J.Hepatocellular carcinoma.Lancet 2003; 362:1907-1917
  • 6[6]Fan ST.Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy.Hepatogastroenterology 2002; 49:17-20
  • 7[7]Makuuchi M,Belghiti J,Belli G,Fan ST,Lau JW,Ringe B,Strasberg SM,Vauthey JN,Yamaoka Y,Yamasaki S.IHPBA concordant classification of primary liver cancer:working group report.J Hepatobiliary Pancreat Surg 2003; 10:26-30
  • 8[8]Takayasu K,Arii S,Ikai I,Omata M,Okita K,Ichida T,Matsuyama Y,Nakanuma Y,Kojiro M,Makuuchi M,Yamaoka Y.Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.Gastroenterology 2006; 131:461-469
  • 9[9]A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma.Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire.N Engl J Med 1995; 332:1256-1261
  • 10[10]Bruix J,Llovet JM,Castells A,Montana X,Bru C,Ayuso MC,Vilana R,Rodes J.Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma:results of a randomized,controlled trial in a single institution.Hepatology 1998; 27:1578-1583

同被引文献4

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部